Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 12;39(7):889-894.
doi: 10.1016/j.ccell.2021.04.015. Epub 2021 May 6.

Progress and potential: The Cancer Moonshot

Norman E Sharpless  1 , Dinah S Singer  2
Affiliations

Progress and potential: The Cancer Moonshot

Norman E Sharpless et al. Cancer Cell. .
No abstract available

PubMed Disclaimer

References

    1. Asnani M, Hayer KE, Naqvi AS, Zheng S, Yang SY, Oldridge D, Ibrahim F, Maragkakis M, Gazzara MR, Black KL, et al. (2020). Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19. Leukemia 34, 1202–1207. 10.1038/s41375-019-0580-z. - DOI - PMC - PubMed
    1. Burga RA, Yvon E, Chorvinsky E, Fernandes R, Cruz CRY, and Bollard CM (2019). Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma (AACR Clinical Cancer Research). 10.1158/1078-0432.CCR-18-3183. - DOI - PMC - PubMed
    1. Evrard YA, Srivastava A, Randjelovic J, Doroshow JH, Dean DA II, Morris JS, and Chuang JH; The NCI PDXNet Consortium (2020). Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis (AACR Cancer Research). 10.1158/0008-5472.CAN-19-3101. - DOI - PMC - PubMed
    1. Finney Rutten LJ, Ruddy KJ, Chlan LL, Griffin JM, Herrin J, Leppin AL, Pachman DR, Ridgeway JL, Rahman PA, Storlie CB, et al. (2020). Pragmatic cluster randomized trial to evaluate effectiveness and implementation of enhanced EHR-facilitated cancer symptom control (E2C2). Trials 21, 480. 10.1186/s13063-020-04335-w. - DOI - PMC - PubMed
    1. Liu D, Schilling B, Liu D, Sucker A, Livingstone E, Jerby-Arnon L, Zimmer L, Gutzmer R, Satzger I, Loquai C, et al. (2019). Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma. Nat. Med 25, 1916–1927. 10.1038/s41591-019-0654-5. - DOI - PMC - PubMed

LinkOut - more resources